abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

기업 응답

2006년 11월 1일

저자:
Novartis

Response by Novartis to statement by Physicians for Social Justice (Nigeria)

Dr. Igboekwu raises many points and we would like to comment on two specific assumptions he makes. The first is that generic competition makes medicines more affordable to patients in the developing world, and the second is that generics are the panacea to enabling access to medicines.

이는 다음에 대한 응답입니다

Physicians for Social Justice (Nigeria) critiques company responses to ICCR report "Benchmarking AIDS"

이야기 2006년 11월 1일

타임라인